Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Dis ; 207(1): 9-17, 2013 Jan 01.
Article in English | MEDLINE | ID: mdl-23166374

ABSTRACT

BACKGROUND: Extensively drug-resistant tuberculosis (XDR-tuberculosis) is a global public health threat, but few data exist elucidating factors driving this epidemic. The initial XDR-tuberculosis report from South Africa suggested transmission is an important factor, but detailed epidemiologic and molecular analyses were not available for further characterization. METHODS: We performed a retrospective, observational study among XDR-tuberculosis patients to identify hospital-associated epidemiologic links. We used spoligotyping, IS6110-based restriction fragment-length polymorphism analysis, and sequencing of resistance-determining regions to identify clusters. Social network analysis was used to construct transmission networks among genotypically clustered patients. RESULTS: Among 148 XDR-tuberculosis patients, 98% were infected with human immunodeficiency virus (HIV), and 59% had smear-positive tuberculosis. Nearly all (93%) were hospitalized while infectious with XDR-tuberculosis (median duration, 15 days; interquartile range: 10-25 days). Genotyping identified a predominant cluster comprising 96% of isolates. Epidemiologic links were identified for 82% of patients; social network analysis demonstrated multiple generations of transmission across a highly interconnected network. CONCLUSIONS: The XDR-tuberculosis epidemic in Tugela Ferry, South Africa, has been highly clonal. However, the epidemic is not the result of a point-source outbreak; rather, a high degree of interconnectedness allowed multiple generations of nosocomial transmission. Similar to the outbreaks of multidrug-resistant tuberculosis in the 1990s, poor infection control, delayed diagnosis, and a high HIV prevalence facilitated transmission. Important lessons from those outbreaks must be applied to stem further expansion of this epidemic.


Subject(s)
Antitubercular Agents/therapeutic use , Cross Infection/transmission , Extensively Drug-Resistant Tuberculosis/transmission , HIV Infections/complications , Mycobacterium tuberculosis/classification , Adult , Cluster Analysis , Cross Infection/complications , Cross Infection/epidemiology , Cross Infection/microbiology , Drug Therapy, Combination , Ethambutol/therapeutic use , Extensively Drug-Resistant Tuberculosis/complications , Extensively Drug-Resistant Tuberculosis/epidemiology , Extensively Drug-Resistant Tuberculosis/microbiology , Female , Genotype , HIV Infections/virology , Hospitals, Rural , Humans , Isoniazid/therapeutic use , Male , Mutation , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/isolation & purification , Polymorphism, Restriction Fragment Length , Prevalence , Pyrazinamide/therapeutic use , Retrospective Studies , Rifampin/therapeutic use , Sequence Analysis, DNA , South Africa/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...